nicotinamide mononucleotide has been researched along with Chronic Illness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lalam, SK; Soma, M | 1 |
| Jiang, WX; Lu, JT; Lu, YB; Tang, C; Wei, EQ; Wu, M; Zhang, WP; Zhang, XQ | 1 |
1 review(s) available for nicotinamide mononucleotide and Chronic Illness
| Article | Year |
|---|---|
The role of nicotinamide mononucleotide (NMN) in anti-aging, longevity, and its potential for treating chronic conditions.
Topics: Aging; Animals; Chronic Disease; Humans; Longevity; Mice; NAD; Nicotinamide Mononucleotide | 2022 |
1 other study(ies) available for nicotinamide mononucleotide and Chronic Illness
| Article | Year |
|---|---|
NAMPT inhibitor and metabolite protect mouse brain from cryoinjury through distinct mechanisms.
Topics: Acrylamides; Acute Disease; Animals; Astrocytes; Brain; Brain Injuries; Calcium-Binding Proteins; Cell Count; Chronic Disease; Cold Temperature; Cytokines; Disease Models, Animal; Macrophages; Male; Mice, Inbred BALB C; Microfilament Proteins; Microglia; NAD; Neurons; Neuroprotective Agents; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Piperidines | 2015 |